Ibrance

Ibrance ATC Classification

palbociclib

Manufacturer:

Pfizer

NEW Brand Resources

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

ATC Classification

L01EF01 - palbociclib ; Belongs to the class of cyclin-dependent kinase (CDK) inhibitors. Used in the treatment of cancer.

Register or sign in to continue

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in

Register or sign in to continue

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in